AIM: Mutations in the SLC16A2 gene have been implicated in Allan-Herndon-Dudley syndrome (AHDS), an X-linked learning disability* syndrome associated with thyroid function test (TFT) abnormalities. Delayed myelination is a non-specific finding in individuals with learning disability whose genetic basis is often uncertain. The aim of this study was to describe neuroimaging findings and neurological features in males with SLC16A2 gene mutations. METHOD: We reviewed brain magnetic resonance imaging (MRI) findings and neurological features in a cohort of five males aged between 1 year 6 months and 6 years (median 4y) from four families harbouring SLC16A2 gene mutations. RESULTS: The participants presented aged between 4 and 9 months with initial hypotonia and subsequent spastic paraparesis with dystonic posturing and superimposed paroxysmal dyskinesias. Dystonic cerebral palsy was the most common initial clinical diagnosis, and AHDS was suspected only retrospectively, considering the characteristically abnormal thyroid function tests, with high serum tri-iodothyronine (T(3)), as the most consistent finding. Brain MRI showed absent or markedly delayed myelination in all five participants, prompting the suspicion of Pelizaeus-Merzbacher disease in one patient. INTERPRETATION: Our findings indicate a consistent association between defective neuronal T(3) uptake and delayed myelination. SLC16A2 involvement should be considered in males with learning disability, an associated motor or movement disorder, and evidence of delayed myelination on brain MRI. Although dysmorphic features suggestive of AHDS are not always present, T(3) measurement is a reliable screening test.
AIM: Mutations in the SLC16A2 gene have been implicated in Allan-Herndon-Dudley syndrome (AHDS), an X-linked learning disability* syndrome associated with thyroid function test (TFT) abnormalities. Delayed myelination is a non-specific finding in individuals with learning disability whose genetic basis is often uncertain. The aim of this study was to describe neuroimaging findings and neurological features in males with SLC16A2 gene mutations. METHOD: We reviewed brain magnetic resonance imaging (MRI) findings and neurological features in a cohort of five males aged between 1 year 6 months and 6 years (median 4y) from four families harbouring SLC16A2 gene mutations. RESULTS: The participants presented aged between 4 and 9 months with initial hypotonia and subsequent spastic paraparesis with dystonic posturing and superimposed paroxysmal dyskinesias. Dystonic cerebral palsy was the most common initial clinical diagnosis, and AHDS was suspected only retrospectively, considering the characteristically abnormal thyroid function tests, with high serum tri-iodothyronine (T(3)), as the most consistent finding. Brain MRI showed absent or markedly delayed myelination in all five participants, prompting the suspicion of Pelizaeus-Merzbacher disease in one patient. INTERPRETATION: Our findings indicate a consistent association between defective neuronal T(3) uptake and delayed myelination. SLC16A2 involvement should be considered in males with learning disability, an associated motor or movement disorder, and evidence of delayed myelination on brain MRI. Although dysmorphic features suggestive of AHDS are not always present, T(3) measurement is a reliable screening test.
Authors: V Herzovich; E Vaiani; R Marino; G Dratler; J M Lazzati; S Tilitzky; P Ramirez; S Iorcansky; M A Rivarola; A Belgorosky Journal: Horm Res Date: 2006-09-15
Authors: Kenton R Holden; Oscar F Zuñiga; Melanie M May; Humberto Su; Marco R Molinero; R Curtis Rogers; Charles E Schwartz Journal: J Child Neurol Date: 2005-10 Impact factor: 1.987
Authors: Knut Brockmann; Alexandra M Dumitrescu; Thomas T Best; Folker Hanefeld; Samuel Refetoff Journal: J Neurol Date: 2005-04-18 Impact factor: 4.849
Authors: M R Passos-Bueno; B C Byth; S Rosenberg; R I Takata; E Bakker; A H Beggs; R C Pavanello; M Vainzof; K E Davies; M Zatz Journal: Am J Med Genet Date: 1993-04-15
Authors: Catherine Vaurs-Barrière; Marlène Deville; Catherine Sarret; Geneviève Giraud; Vincent Des Portes; José-Maria Prats-Viñas; Giuseppe De Michele; Bernard Dan; Angela F Brady; Odile Boespflug-Tanguy; Renaud Touraine Journal: Ann Neurol Date: 2009-01 Impact factor: 10.422
Authors: Hideyuki Iwayama; Xiao-Hui Liao; Lyndsey Braun; Soledad Bárez-López; Brian Kaspar; Roy E Weiss; Alexandra M Dumitrescu; Ana Guadaño-Ferraz; Samuel Refetoff Journal: Thyroid Date: 2016-08-23 Impact factor: 6.568
Authors: Stacey J Ellery; Meredith Kelleher; Peta Grigsby; Irina Burd; Jan B Derks; Jon Hirst; Suzanne L Miller; Larry S Sherman; Mary Tolcos; David W Walker Journal: J Physiol Date: 2018-07-21 Impact factor: 5.182
Authors: Daniela López-Espíndola; Carmen Morales-Bastos; Carmen Grijota-Martínez; Xiao-Hui Liao; Dorit Lev; Ella Sugo; Charles F Verge; Samuel Refetoff; Juan Bernal; Ana Guadaño-Ferraz Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958